The more than 233,000 bottles of duloxetine contain the "presence" of nitrosamine drug substance impurity, ...
An SNRI (serotonin and norepinephrine reuptake inhibitor) is one of two major classes of medications used to treat clinical ...
Certain bottles and doses of duloxetine, a common antidepressant, have been recalled due to the presence of potentially cancer-causing chemicals. The recall was initiated on Nov. 19 by manufacturer ...
Cymbalta is used to treat mental health disorders. The bottles were distributed nationwide, according to the FDA.
In three separate reports, the FDA said that various doses of duloxetine delayed-release capsules were recalled due to the ...
The bottles were distributed nationwide, including in Wisconsin, and received the FDA's second-most severe risk ...
Over 200,000 bottles of the antidepressant duloxetine have been recalled due to higher-than-acceptable levels of ...
Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing impurities.
Over 8 million U.S. adults take antidepressants to treat mild to moderate depression, anxiety and, in some cases, chronic ...
In October, The FDA initially announced a Class II recall for just 7,107 bottles of duloxetine capsules distributed by Towa Pharmaceutical Europe. According to the FDA, 233,003 bottles have been ...